SHANGHAI HAOHAI BIOLOGICAL TEC's ticker is and the CUSIP is 00BWZN1R1. A total of 1 filers reported holding SHANGHAI HAOHAI BIOLOGICAL TEC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $393,000 | -49.8% | 122,255 | -17.4% | 0.10% | -41.7% |
| Q2 2022 | $783,000 | -16.3% | 148,071 | -19.9% | 0.18% | -8.4% |
| Q1 2022 | $935,000 | -40.0% | 184,815 | -21.7% | 0.19% | -33.7% |
| Q4 2021 | $1,558,000 | +29.4% | 235,915 | +57.8% | 0.29% | +26.3% |
| Q3 2021 | $1,204,000 | -59.4% | 149,457 | -38.1% | 0.23% | -45.5% |
| Q2 2021 | $2,963,000 | +50.1% | 241,448 | -6.7% | 0.42% | +12.7% |
| Q1 2021 | $1,974,000 | +111.1% | 258,848 | +67.1% | 0.37% | +109.6% |
| Q4 2020 | $935,000 | +22.9% | 154,873 | +34.8% | 0.18% | +5.4% |
| Q3 2020 | $761,000 | – | 114,869 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Legato Capital Management LLC | 258,848 | $1,974,000 | 0.37% |